THE PREDICTIVE VALUE OF NOVEL INFLAMMATORY MARKERS FOR SILENT MYOCARDIAL ISCHEMIA IN HIGH-RISK DIABETIC PATIENTS: A RETROSPECTIVE COHORT STUDY
Background: Silent myocardial ischemia (SMI) is a major cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM), yet routine screening protocols remain suboptimal. Emerging evidence suggests that novel inflammatory ratios, such as the Neutrophil-to-Lymphocyte Ratio (NLR) and the Platelet-to-Ly...